Get started
Author

Masanori Toho

Observed name: Toho M
ORCID: 0009-0007-5823-8395
Observed ORCID: 0009-0007-5823-8395
OpenAlex ID: A5040823391
Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma
2024 · Daisuke Ikeda, Shuichi Aikawa, et al. · Blood · 21
Serum B-cell maturation antigen could be a simple and accurate biomarker to identify and prognosticate monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
2025 · Masanori Toho, Daisuke Ikeda, et al. · Haematologica · 5
PDF
Myeloid sarcoma and pathological fracture: a case report and review of literature
2023 · Sho Takeyasu, Ken Morita, et al. · International Journal of Hematology · 5
PDF
Soluble BCMA as a biomarker reflecting tumor volume and treatment response in Waldenström macroglobulinemia
2025 · Mitsuaki Oura, Daisuke Ikeda, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 4
Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton’s tyrosine kinase inhibitor and bispecific antibody therapy
2026 · Mitsuaki Oura, Masanori Toho, et al. · Frontiers in Oncology · 2
PDF
Different Patterns of Antigen Expression in Bone Marrow and Circulating Tumor Plasma Cells in Patients with MGUS and Smoldering Multiple Myeloma
2024 · Atsushi Uehara, Fuminari Fujii, et al. · Blood · 2
Soluble BCMA As a Surrogate Biomarker for Tumor Burden in Multiple Myeloma: Correlations with Various Biomarkers and Treatment Responses
2024 · Rikako Tabata, Mitsuaki Oura, et al. · Blood · 2
Soluble B-Cell Maturation Antigen Levels for Disease Monitoring in Oligo- and Non-Secretory Relapsed Multiple Myeloma
2024 · Daisuke Ikeda, Shuichi Aikawa, et al. · Blood · 1
Adult T-cell leukemia-lymphoma with neurolymphomatosis successfully controlled by valemetostat: a case report and review of literature
2024 · Masanori Toho, Megumi Yasunaga, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
Primary Extranodal Diffuse Large B-cell Lymphoma Presenting in the Lips: A Case Report and Literature Review
2024 · Hideshige Seki, Ken Morita, et al. · Internal Medicine · 1
PDF
MU314, a novel selective estrogen receptor modulator (SERM), improves estrogen-dependent depressive behaviors
2017 · Izumo N, Ishibashi Y, et al. · Global Drugs and Therapeutics · 1
PDF
Soluble BCMA Defines Spatial Phenotypes and Prognosis in Newly Diagnosed Multiple Myeloma
2026 · Masanori Toho, Rikako Tabata, et al. · Blood
Parkinsonism-like delayed neurotoxicity after idecabtagene vicleucel therapy for multiple myeloma: clinicopathological, cerebrospinal fluid, and autopsy analyses
2026 · Hiroki Yoshino, Tatsuya Imi, et al. · Haematologica
PDF
Treatment‐specific differences in soluble B‐cell maturation antigen levels at minimum residual disease negativity in multiple myeloma
2026 · Masanori Toho, Rikako Tabata, et al. · British Journal of Haematology
A Case of Recurrent COVID-19 Pneumonia Following Rituximab Therapy: Treatment Informed by a Serial Transbronchial Lung Cryobiopsy, BALF SARS-CoV-2 PCR, and the Clinical Course
2026 · Jun Hayashi, Tatsuya Nagai, et al. · Internal Medicine
PDF
Impact of the plasma cell quantification method on the International Myeloma Working Group diagnostic criteria for MGUS/SMM
2025 · Atsushi Uehara, Hajime Sakuma, et al. · Haematologica
PDF
Distinct immunophenotypic profiles of circulating tumor plasma cells in MGUS and smoldering multiple myeloma
2025 · Atsushi Uehara, Kentaro Narita, et al. · International Journal of Hematology
Tracking MRD in multiple myeloma: Soluble BCMA reflects flow cytometry changes
2025 · Masanori Toho, Rikako Tabata, et al. · Blood
Radiomic features from PET-CT enable diagnostic and prognostic stratification in peripheral T-cell lymphoma
2025 · Hajime Sakuma, Daisuke Ikeda, et al. · Blood
PDF
Clinical and radiological prediction models for random skin biopsy positivity in suspected intravascular large B-cell lymphoma: development and internal validation
2025 · Hajime Sakuma, Kentaro Narita, et al. · Leukemia & lymphoma/Leukemia and lymphoma
Clinicopathological Analysis of Parkinsonism-like Neurotoxicity after BCMA-Directed CAR-T Therapy: An Autopsy Case With Idecabtagene-Vicleucel
2025 · Tatsuya Imi, Hiroki Yoshino, et al. · Clinical Lymphoma Myeloma & Leukemia
Serum BCMA Is a Better Reflector of Tumor Volume Than IgM in the Induction Period of Waldenström Macroglobulinemia
2024 · Mitsuaki Oura, Daisuke Ikeda, et al. · Blood
Simultaneous Assessment of Total Metabolic Tumor Volume and Intratumoral CD4+ T-Cell Infiltration Identifies Early Progression of Follicular Lymphoma on Watch-and-Wait Approach
2024 · Fuminari Fujii, Daisuke Ikeda, et al. · Blood
Works count: 23
Citation count: 45
H-index: 4
I10-index: 1
Year
Topic
Type